Attached files

file filename
EX-32 - EX-32 - ELI LILLY & Coc54269exv32.htm
EX-10 - EX-10 - ELI LILLY & Coc54269exv10.htm
EX-12 - EX-12 - ELI LILLY & Coc54269exv12.htm
EX-31.2 - EX-31.2 - ELI LILLY & Coc54269exv31w2.htm
EX-31.1 - EX-31.1 - ELI LILLY & Coc54269exv31w1.htm
EXCEL - IDEA: XBRL DOCUMENT - ELI LILLY & CoFinancial_Report.xls
10-Q - FORM 10-Q - ELI LILLY & Coc54269e10vq.htm
EXHIBIT 11.   STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE
(Unaudited)
Eli Lilly and Company and Subsidiaries
                                 
    Three Months Ended   Nine Months Ended
    September 30,   September 30,
    2009   2008   2009   2008
    (Dollars and shares in millions except per-
share data)
       
BASIC
                               
Net income (loss)
   $ 941.8     $ (465.6 )   $ 3,413.4     $ 1,557.5  
     
Average number of common shares outstanding
    1,094.8       1,092.2       1,094.5       1,091.9  
Contingently issuable shares
    2.9       1.8       2.9       2.0  
           
Adjusted average shares
    1,097.7       1,094.0       1,097.4       1,093.9  
     
Basic earnings (loss) per share
   $ .86     $ (.43 )   $ 3.11     $ 1.42  
     
DILUTED
                               
Net income (loss)
   $ 941.8     $ (465.6 )   $ 3,413.4     $ 1,557.5  
     
Average number of common shares outstanding
    1,094.8       1,092.2       1,094.5       1,091.9  
Incremental shares — stock options and contingently issuable shares
    2.9       1.8       2.9       2.0  
           
Adjusted average shares
    1,097.7       1,094.0       1,097.4       1,093.9  
     
Diluted earnings (loss) per share
   $ .86     $ (.43 )   $ 3.11     $ 1.42